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Abstract 
The cell cycle process called endoreduplication is a specialized form of DNA replication. 
Cells do not divide and instead continually undergo G and S phase and as a result, increase their 
ploidy and size. Endoreduplication is important for normal development in cells such as 
hepatocytes, giant trophoblasts, and megakaryocytes.  
However, it has also been discovered that cancer cells utilize endoreduplication in order 
to escape apoptosis when exposed to chemotherapeutic drugs which inhibit mitosis. Thus, it is 
important to identify endoreduplication specific genes in order to fully understand the regulation 
mechanisms which are essential for development. Moreover, our previous work and work from 
other labs has demonstrated that endoreduplication uses machinery as well as regulatory 
mechanisms which are fundamentally different from those used in mitotic replication. 
In order to identify endoreduplication-specific factors, I have begun a genome-wide 
screening of ~12000 Drosophila melanogaster genes, each possessing a human homologue. The 
basis of the screen is a very powerful tool called the GAL4/UAS system, which has proven 
invaluable when coupled with the RNA interference (RNAi) pathway.  Combining the GAL/UAS 
system with UAS>RNAi enables us to test the effects of downregulating each gene. The genome-
wide screen consists of two concurrent screens. The first is a screen through endocycling and 
mitotically cycling tissue to identify endoreduplication specific factors. The second consists of 
screening for essential genes for the transition from mitotic replication to endoreduplication. 
Currently, I have screened 1280 lines and are further studying candidate genes using clonal 
analysis and flow cytometry techniques. I expect that one percent of the genes (~10 genes) of the 
1280 will be related to endoreduplication and estimate that one percent of the Drosophila 
genome (~120) will be related to endoreduplication.  
Introduction 
During development, organisms use the mitotic cycle and the endocycle for different 
purposes.  In the mitotic cycle, the cell undergoes G1, S, G2, and finally M phase to increase cell 
number.  However, in the endocycle, the cell solely undergoes G phase then S phase and repeats 
this process.  In other words, the cell increases its ploidy and size by skipping cell division. (1) 
 Our laboratory has found that the factors in endoreduplication differ from those in mitotic 
replication in Drosophila melanogaster.  In mitotic replication, the Origin Recognition Complex 
(ORC), the funding member that initiates formation of the Pre-Replicative complex (pre-RC), is 
required to recruit Cell division cycle 6 (Cdc6), Double Parked (Dup), and MCM (Mini 
Maintenance Chromosome) to form the pre-RC.  However, in endoreduplication, the Asano lab 
has found that the ORC is dispensable but Dup, Cdc6 and MCM are necessary. (Figure 1) (2) 
These results tell us that endoreduplication and mitotic replication use different machinery.  As 
Cdc6 and Dup do not bind to the DNA on their own, the Asano lab predicts that another protein 
or group of proteins is responsible for initiating pre-RC formation.  
 Determining the initiation machinery and control mechanisms of endoreduplication is 
important because certain types of cancer cells are known to undergo endoreduplication when 
treated with anti-mitotic drugs. (3) To identify the genes involved in the control of cell type-
specific endoreduplication, the factors involved in the transition from mitotic replication to 
endoreduplication, and genes generally involved in endoreduplication, our lab decided that a 
genome-wide screening was not only practical, but also essential. However, currently there is no 
intact organism available for a genome-wide screening in any mammalian system.  In order to 
circumvent this problem, I am implementing Drosophila melanogaster as a model system and 
the RNAi library I am screening contains selectivity against genes all of which possess human 
homologues. 
Findings from this project will open up an entirely new window for studying DNA 
replication, signaling pathways that control the transition from mitotic replication to 
endoreduplication during organism development, and will pave the way for another approach 
toward curing cancer. 
 
Methodology 
The basis for the genome-wide screening is a powerful system called the GAL4/UAS 
system coupled with the RNAi pathway. (Figure 2) 
 
GAL4/UAS System 
The GAL4/UAS system utilizes the transcription factor activator protein Gal4 which binds 
to the Upstream Activator Sequence (UAS). When the Gal4 protein binds to the UAS it activates 
the gene downstream of the UAS. In this sense, Gal4 protein ‘drives’ gene expression. (4) The 
GAL4/UAS system has several distinct advantages over other methods. The first advantage is the 
ability to express genes in a developmental-specific and tissue-specific manner. Transcription of 
Gal4 protein is under the control of a promoter which is only activated in certain subsets of fly 
tissues or during certain periods of development. The second benefit is that 5638 GAL4 drivers 
are available in Bloomington Stock Center. Thus, one can simply choose and order the GAL4 
drivers desired for different experiments. Moreover, benefit of using the GAL4/UAS system is 
viability of transgenic flies. Ubiquitous expression of potent genes might kill a mutant fly. 
However, since the GAL4 and UAS transgenes are separated in two different fly lines, the system 
is inert until when two fly lines are crossed and produce progeny which contain both transgenes.  
As a result, I can maintain healthy flies until I cross them to ascertain the effects of the gene of 
interest on the fly. Because the GAL4/UAS system is so versatile, it has been thoroughly 
characterized and successfully tested in various Drosophila projects including other screenings 
of to identify genes involved in various cellular processes.  (5) GAL4 driver selection will be 
addressed below. 
 
RNAi Pathway 
 The other half of the screening implements what is known as RNA interference (RNAi). 
RNAi is a well studied pathway originally characterized in Caenorhabditis elegans which 
moderates gene activity. (7) Activity of the RNAi pathway is controlled by the RNA-Induced 
Silencing Complex (RISC). (Figure 3) Trigger RNA (consisting of either dsRNA or miRNA) 
activates the pathway. Dicer binds and cleaves the trigger RNA into fragments called small-
interfering RNA (siRNA) and the siRNA is integrated into the RISC complex. Next, using the 
integrated siRNA, RISC searches for and targets matching mRNA strands. Targeted mRNA by 
the RISC complex is translationally inhibited in two ways: either by degradation via a protein 
called Slicer or by continued binding of the RISC complex to the mRNA.  
 By combining the GAL4/UAS system with the RNAi pathway, I am able to downregulate 
gene expression in a tissue-specific manner. Using this as the basis, I plan to screen 11000 genes 
out of 14000 of Drosophila, essentially the entire genome. The transgenic lines expressing RNAi 
are from Vienna Drosophila RNAi Center (VDRC) and each targets one gene of the Drosophila 
genome. An UAS sequence is upstream of the RNAi which allows Gal4 to drive RNAi 
expression. Moreover, each gene of the 11000 targeted by RNAi has a human homologue which 
I am most interested in because I would like to extend the findings of my research to mammals in 
the future. 
 
FACS Analysis 
The FACS analysis involves dissecting ovaries from female flies, purifying their cells, 
and examining the DNA content profile of follicle and nurse cells. The protocol I used was 
developed by Dr. Brian Calvi and Dr. Mary Lilly. (14) I have adapted and conditioned certain 
steps of the protocol to fit my experiments. The first step is to cross the follicle cell and nurse 
cell RNAi candidates to their drivers (c355>GAL4 and VP16nos>GAL4 respectively). After 11 
days, I put the flies in a cage with an apple juice-agar plate. This plate has yeast paste spread in 
the middle of it to stimulate oogenesis. The plate is replaced with another apple juice-agar plate 
spread with yeast paste twice a day until day 14. Then, my peers and I dissect out the ovaries of 
the progeny in Ephrussi-Beadles Ringer’s (EBR) (130 mM NaCl, 5 mM KCl, 2 mM CaCl2, 10 
mM HEPES, pH 6.9; autoclave and store at 4° C) solution. Conditioning experiments revealed 
that dissecting out 40 pairs of ovaries for the follicle cells and 60 pairs of ovaries for the nurse 
cells yields enough cells for the FACS analysis. We place these ovaries in individual 
microcentrifuge tubes, suspending them in EBR. Next, we suspend the ovaries in 10 mg/ml 
collagenase to digest the connecting tissue of the ovarioles for 15 minutes while rotating the 
tubes. After digestion, we rinse the ovaries with EBR twice and resuspend the digested ovaries in 
nuclear isolation buffer with 1.5% NP-40 (15 mM Tric-HCl, pH 7.4, 60 mM KCl, 15 mM NaCl, 
250 mM sucrose, 1 mM EDTA, 0.1 mM EGTA, 0.15 mM spermine, 0.5 mM spermidine).  Then, 
we homogenize the ovaries, filter them twice through filter tips, and layer the samples on a 
sucrose step gradient which, from most dense on the bottom to least dense on the top, consists of 
2.5-M, 1.6-M, and 0.8-M sucrose (dissolved in nuclear isolation buffer). Finally, we place the 
samples in the ultracentrifuge for 1 hour at 25000 rpm. When it is done, resuspend the pellet in 
nuclear isolation buffer and put DAPI in each sample.  
 
Clonal Analysis 
The clonal analysis has 3 components: a Heat Shock promoter (heat shock protein 70 aka 
hsp>70), FLP recombinase, the GAL4/UAS system.  (Figure 12) hsp70 is induced to act in high-
stress environments, for example under conditions where the environment is above an acceptable 
level for organismal development. Once induced, the gene under control of the heat shock 
promoter, in the case FLP recombinase and ‘flip out’ these sites which allows the GAL4 driver, 
Act5c>GAL4, to be ubiquitously expressed. As the CD2>Act5c>Cd2 allele is linked to 
UAS>RFP, the cells in which Act5c protein is active can be distinguished by the presence of 
RFP. Using UAS>RFP allows comparison of cells expressing the RNAi to those that are not. 
Because the ‘flip-out’ event occurs in one or two cells in each salivary gland, it is possible to 
screen for cell autonomous interactions. In practice, the progeny of the GAL4 driver crossed to 
the candidate are heat-shocked, one or two cells expressing the UAS>RNAi surrounded by other 
cells which are not can be observed. As a result, one will be able to directly compare cells 
expressing the candidate RNAi which will be red due to the RFP to cells which are not. It is 
expected that if the candidate is needed in endoreduplication, and functions cell autonomously, 
then the RNAi-expressing cells will be smaller in size to control cells around it. However, if the 
candidate is not expressed in a cell autonomous manner, the RFP minus cells surrounding the red 
cell will also demonstrate endoreduplication defects.   
 
Results 
Pre-screening for Gal4 Drivers 
When I finished the pre-screening, I had selected three different GAL4 drivers. They are 
dppblk1>GAL4, c355>GAL4, and VP16nos>GAL4. I chose these GAL4 drivers because they 
demonstrated strict tissue specificity and because the phenotypes of the GAL4 drivers when 
expressing RNAi are easily screenable. dppblk1>GAL4 is expressed in larval salivary glands and 
wing imaginal discs (in the larval wing discs which develop and become adult wings), 
c355>GAL4 is expressed in ovarian follicle cells, and VP16nos>GAL4 is expressed in germline 
nurse cells. 
I originally aimed to distinguish factors involved specifically in endoreduplication from 
factors involved in both endoreduplication and mitotic replication. To do so, I needed to identify 
a driver which would be suitable to screen for genes which may be involved in mitosis or other 
processes, such as metabolism, but not involved in the endoreduplication machinery itself. I 
defined a ‘suitable’ driver as one which demonstrated tissue-specific expression and had a 
phenotype which one could screen quickly, spending less than ten seconds analyzing each RNAi 
line. The first GAL4 drivers I screened were GMR>GAL4 and eyeless>GAL4. Both are 
expressed in mitotically replicating eye imaginal discs and have been utilized in multiple screens 
by other laboratories. (8, 9) Although information regarding these drivers is available in stock 
center databases, I decided to test them because UAS>RNAi expression may potentially change 
the GAL4 driver activity. To do so, I crossed them to six UAS>RNAi lines specific for factors 
known to be involved with endoreduplication and genes involved with Drosophila development. 
I used UAS>fru, a gene involved with male courtship and not endoreduplication, as a negative 
control. (Figure 5B and C) However, when I screened the eyes of the progeny, GMR>GAL4 did 
not yield a suitable phenotype for the screening because the phenotype varied drastically from an 
orange eye color to the wild type eye color (red) to a dark red eye color. The change in eye color 
is concerning because each of the progeny possesses one allele of the GAL4 driver and the one 
allele of the RNAi transgene with no other transgenes which may influence eye color. As a 
result, the eyes throughout all of the progeny ought to be the same eye yet after performing the 
experiment, this was clearly not the case. Variation of eye color makes judging more difficult 
thus it would take longer to screen which was undesirable. In addition, there were variable 
ranges of ‘rough’ eye phenotype, the driver itself demonstrating a mild version of the rough eye 
phenotype without any UAS>RNAi which caused worry in regards to false positives for mitotic 
replication. eyeless>GAL4 phenotypes did not vary as much but they were too extreme. The 
progeny either had little or no eyes or were pupal lethal and did not develop into a mature adult 
flies.  
Learning that the tested eye GAL4 drivers were not suited for my screening, I researched 
GAL4 drivers expressed in wing discs, another mitotically cycling tissue. I decided to pre-screen 
ms1096>GAL4 and en>GAL4 because they had been utilized in other laboratories and were 
readily available in the lab. However, after crossing the GAL4 drivers to the same RNAi 
transgene used in the previous eye screen, I did not observe any clear phenotype using either 
GAL4 driver. There was no difference between a wild-type fly wing and the wings of the 
GAL4/UAS progeny.  
At this point, I decided to ask for suggestions from Dr. Amanda Simcox because her 
research is involved in wing disc expression. She recommended three GAL4 drivers to screen for 
mitotically replicating tissue and/or endoreduplicating tissue which is dppblk1>GAL4, ptc>GAL4 
and 71B>GAL4. In my pre-screen, I compared the expression of these three GAL4 drivers in 
endoreduplicating larval salivary gland tissue.  To easily visualize the salivary glands, I 
genetically modified each of the three GAL4 driver alleles to recombine with UAS>GFPnls 
alleles, which encodes Green Fluorescent Protein with a nuclear localization signal. The GFPnls 
is also downstream of an UAS sequence so it is activated by any Gal4 protein which binds to it.  
I also added and tested UAS>Dcr-2 (Dcr-2 under control of GAL4/UAS) to see if there 
was a significant difference in RNAi effects with and without Dcr-2. (10)  Each driver was 
crossed to the same UAS lines used in the eye screen described above. Based on distributions of 
UAS>GFPnls signal, all three drivers yielded similar phenotypes in larval salivary glands with 
and without UAS>Dcr-2. The experiment demonstrated that crosses with UAS>Dcr-2 seemed to 
enhance the phenotypes. (Figure 4A and C and 5A)  As a result, we decided to use ptc>GAL4 
recombined with UAS>GFPnls and UAS>Dcr-2 based on the data from the pre-screen as well as 
previous driver characterization from past experiments. (4) 
While screening the three salivary gland drivers, I learned from Dr. Simcox that 
dppblk1>GAL4 was expressed in both mitotically replicating wing discs and endoreduplicating 
larval salivary glands. In consequence, I tested this driver against the same UAS lines from the 
previous pre-screening experiments using GAL4 drivers expressed in the eye. While there were 
four pupal lethal progeny, the expressivity of the GAL4 driver phenotype was more easily 
observed and it was very simple to score the varying strengths of the phenotype. (Figure 4B and 
D) Because the phenotype given by dppblk1>GAL4 in larval salivary glands was comparable to 
the phenotype of ptc>GAL4, I decided to use dppblk1>GAL4 also as the salivary gland driver. 
This driver seemed to perfectly suit the screen because I would be able to use one driver to 
screen two tissues which would expedite the screening process more by not having to cross 
UAS>RNAi lines to another driver and it would also save resources.  
The Notch pathway has been shown to regulate the switch from mitosis to the endocycle 
in ovarian follicle cells.  (11)  After learning this, I realized that there is the possibility that some 
genes might only regulate the switch from mitotic replication to endoreduplication rather than 
regulating endoreduplication per se. For this purpose, I sought out a driver which would be 
expressed in ovarian follicle cells. During oogenesis, ovarian follicle cells switch from mitotic 
replication to endoreduplication from Stage 6 to 7 and are very well studied making them a high-
priority tissue to screen. (Figure 5D) (12)  My advisor, Dr. Maki Asano, and a former P.D. in our 
lab, Dr. So Young Park, had screened the expression of several ovarian follicle cell GAL4 drivers 
using UAS>GFPnls. (Figure 5E) Given this data, I decided to pre-screen c355>GAL4 because 
expression of this driver begins from Stage 6 and continues onwards through oogenesis allowing 
me to screen for factors involved in the switch from mitotic replication to endoreduplication. I 
pre-screened c355>GAL4 by crossing it to the UAS>RNAi lines used above. To screen for 
phenotypes, I dissected out the ovaries and visualized the nuclei with DAPI. Three crosses were 
pupal lethal but the other three gave a sterility phenotype as well as decreased size of follicle 
cells around the egg chamber during oogenesis. I did not combine this driver with UAS>GFPnls. 
It seemed too complicated to transgenically modify the driver since the gene is on the first 
chromosome. I did not carry out the pre-screen with UAS>Dcr-2 either because, given the 
amount of progeny which were lethal, there was a high chance that co-expressing Dcr-2 would 
not yield adults or adults without ovaries. 
 At this point in the pre-screening, I realized both GAL4 drivers I had selected thus far 
were expressed in epithelial cells. dppblk1>GAL4 is expressed in larval salivary glands and 
c355>GAL4 in ovarian follicle cells. As I am primarily interested in ‘generic’ endoreduplication 
factors that are required in the various cell types, I decided to screen germline nurse cells. I was 
already using ovaries to screen follicle cells and it would give me another assay in which to 
screen for endoreduplication-specific factors. The driver I chose to use was VP16nos>GAL4 
because it is a well characterized and has been successfully tested. (Figure 5F) (13)  Using 
VP16nos>GAL4, I compared the effects of UAS>Dcr-2 in the nurse cells. We dissected out and 
visualized the ovaries of the progeny with UAS>GFPnls as well as stained them with DAPI. The 
results between the two varied a lot. The transgenic VP16nos>GAL4 line without UAS>Dcr-2 
did not yield any phenotype while the transgenic line containing UAS>Dcr-2 did. For instance, 
some yielded ovaries with increased numbers of nurse cells and with smaller nuclei in Dcr-2(+) 
crosses while Dcr-2(-) did now. This demonstrates inhibition of endoreduplication.  
  
Genome-wide Screening of Drosophila 
Using three drivers identified from the pre-screening, I moved on to the ‘pilot’ screen. 
The first, used to screen larval salivary glands and adult wing tissue, is dppblk1>GAL4 which also 
encodes UAS>Dcr-2 and UAS>GFPnls. The second is c355>GAL4 and it is used to screen 
ovarian follicle cells. The third is VP16nos>GAL4 transgenically modified to carry 
UAS>GFPnls and UAS>Dcr-2. I grew five sublines for dppblk1>GAL4 and c355>GAL4 and ten 
sublines for VP16nos>GAL4 because VP16nos>GAL4 viability is not as high as the other two.  
Drosophila development usually occurs in the span of 10 days. (Figure 6A) To increase 
efficiency, I developed a screening schema. (Figure 6B-E) I order 160 UAS>RNAi lines from 
Vienna Drosophila RNAi Center every week. They are in sequential order according to their line 
number. When the lines arrived, I transfer them into new vials. Before the UAS>RNAi lines 
arrive, my peers and I collect virgins from the GAL4 driver sublines. Next, we aliquot and cross 
GAL4 driver virgins to males containing the UAS>RNAi transgene. After three to four days, I 
discard the parents of each cross to prevent confusion between parents and progeny when the 
progeny fully emerge. After five to six days, I screen larval salivary glands of the dppblk1>GAL4 
crosses. After 10 or 11 days, I screen the wing tissue of the progeny of the dppblk1>GAL4. On the 
same day, I also aliquot three to four male and three to four female progeny from the cross 
c355>GAL4 and VP16nos>GAL4 crosses into new vials. I check for fertility after three to four 
days. 
Scoring phenotypes was done by using a system refined from the range of phenotypes in 
pre-screening data. The UAS>RNAi lines which we find to be the most interesting for 
dppblk1>GAL4 are those which yielded a salivary gland medium strength or stronger phenotype 
(i.e. salivary glands which were at least less than half of the control salivary gland size) was with 
no, or a very mild, wing phenotype. The lines which were most interesting for c355>GAL4 and 
VP16nos>GAL4 were those which yielded progeny that demonstrated semi-sterile (severe 
reduction in fertility) or sterile phenotype. 
After scoring the ~1280 RNAi lines, we decided to further characterize the positive 
candidates received from the pilot screen. To do so, we utilized Fluorescence Activated 
Cytometry Sorting (FACS) for follicle and nurse cell candidates and clonal analysis for the 
salivary gland candidates. (Figure 11 and 12) The follicle and nurse cell positive candidates were 
screened using the fertility. The FACS analysis allows me to look at the ploidy of the follicle and 
nurse cells and I have a clearer idea if the sterile phenotype is caused by a shift in ploidy due 
downregulation of endoreduplication-specific factors or those involved in the switch from 
mitosis to the endocycle, or if it is attributed to another process not related to endoreduplication. 
The clonal analysis allows me to distinguish if change in cell nuclei size is occurring in a cell 
autonomous manner. Additionally, it allows me to separate candidates specifically involved in 
endoreduplication from those which may be involved in other cellular processes affecting cell 
size such as metabolism. 
I ran a FACS analysis on the 58 candidates identified though the follicle cell screen and 
found that 20 of them yielded a shift in ploidy. This was determined by looking at trends in the 
data and establishing a cutoff point. I saw that there were several crosses which revealed a slight 
shift in ploidy, a 10% difference in the 16N peak from the control. However, these did not show 
a significant shift otherwise so I decided to separate the more interesting candidates, those which 
showed a decrease in the 16N peak by at least 10% complemented by an increase in the lower 
ploidy peaks, from those which do not yield a significant enough phenotype. While the FACS 
analysis for the candidates identified from the follicle cell screen went smoothly, the nurse cell 
FACS analysis required a lot of troubleshooting. Since I was not receiving constant profiles for 
the nurse cell candidates, I referenced the original protocol and adjusted conditions accordingly. 
The primary experimental conditions that I changed were the centrifuge time and speed as well 
as the concentration of collagenase. Calvi BR and Lilly MA use 14000 rpm in their protocol for 
20 minutes. In addition, they use 5 mg/ml collagenase. I changed one variable in each 
conditioning experiment. When I changed the centrifuge time to 20 minutes, this did not affect 
the data at all. Next, I adjusted the centrifuge speed from 25000 rpm to 14000 rpm but this 
produced even worse results. However, when I changed the concentration of the collagenase 
from 10 mg/ml to 5 mg/ml, I saw much better results. In consequence, I decided to use 5 mg/ml 
collagenase, centrifuging at 25000 rpm for 20 minutes. I chose 20 minutes since it is more true to 
the original protocol and did not seem to matter if the samples were centrifuged for 20 minutes 
or an hour. 
 
 
Discussion 
Out of the 1280 genes screened in the pilot screening, 216 genes were identified as 
having possible function in endoreduplication and/or the switch from mitosis to 
endoreduplication. (Figure 7) Three of these are of particular interest because they all 
demonstrated possible involvement in endoreduplication in all three tissues. Nucleoporin 54 
(Nup54) is involved in the creation of cytoplasmic compartments in the nuclear envelope. 
Whgsc2 is a gene which has not been characterized very much. Cp7Fa is an uncharacterized 
gene which does not have any known mouse of human homologues.  Out of all of these, I have 
only characterized Nup54 via the FACS and have yet to do a clonal analysis on it. The 
UAS>RNAi lines for Whgsc2 and Cp7Fa did not reproduce well and were lost. We plan to 
reorder them and characterize them as soon as possible. Looking at DNA/Endo reports for 
Nup54 has revealed that Nup54 expression is high in early Drosophila embryonic development, 
moderately expressed throughout larval and pupal stages, and then is highly expressed again in 
adult males and females. Moreover, it is moderately expressed in larval salivary glands and in 
ovaries. Moreover, it is involved with protein importation, more specifically with direct 
interaction with the NLS-bearing substrate, into the nucleus. There are also known orthologs in 
Caernorhabditis elegans, Xenopus tropicalis, and Mus musculus. When taking the screening data 
into account and after characterizing using bioinformatics, this gene has high potential to be 
involved in endoreduplication. There is one available allele from Bloomington Stock Center and 
this will be analyzed using more hypothesis-driven methods.  
Many candidates demonstrated a severe salivary gland phenotype and did not develop 
into viable adults. In addition, many UAS>RNAi lines when crossed to the follicle cell GAL4 
driver, c355>GAL4, did not yield viable adults and prevented me from performing a fertility 
check or FACS analysis. This lethality may be attributed to a lack of specific gene expression. 
For example, His2B/CG33868 is a gene needed for histone integrity. If it is compromised, the 
DNA in cells will be mutated or destroyed causing the specific developmental disc to not 
develop properly. If this occurs, the organism will not be able to become a mature, adult fly. 
Another possibility for lethality might be due to metabolism genes. Many cells, especially the 
enormous larval salivary gland cells, require large amounts of nourishment. If an RNAi line 
targets expression of a gene, like CG9512/Glucose Dehydrogenase, essential towards glucose 
metabolism, cells will not be able to develop properly. This might cause cells, such as salivary 
gland cells which are normally very large, to seem smaller not because of a defect in 
endoreduplication, but due to a metabolism defect.  
To find what types of functions the candidates from the primary screening are assigned, I 
ran a PANTHER (Protein ANalysis THrough Evolutionary Relationships). (Figure 8, 9 and 10) 
When interpreting the data from PANTHER, I have to keep in mind several aspects which might 
change the way I interpret the PANTHER data. One is that the candidates identified from the 
salivary gland and nurse cell screen have a high number of RNA binding proteins, which are 
likely to be involved in translation. This interpretation is consistent with the fact that salivary 
gland cells and nurse cells are much larger than follicle cell so that they require a higher 
metabolism. These proteins are probably not involved in an endoreduplication-specific manner 
and will be excluded through the secondary screening. A particular intriguing category of 
proteins are the DNA-binding proteins which yielded comparable numbers of candidates from 
each tissue screen. These proteins are interesting because DNA-binding proteins may include 
transcription factors which may be involved in endoreduplication-specific regulation. However, 
since the number of candidates included in the PANTHER is small, it is hard to draw definitive 
conclusions. As the screening continues, the data will become more reliable because there will be 
a larger pool of candidates.  
There are three goals for the future. The first is to complete the secondary screening for 
the candidates identified from the salivary gland and nurse cell screens. There are still 90 nurse 
cell candidates which have not been screened by FACS Analysis. I expect that the percentage of 
remaining number of candidates will be similar to the candidates identified in the follicle cell 
screening. Out of 58 potential candidates identified from the follicle cell fertility screen, 20 
remain demonstrating that only 40 percent of the lines remain. However, 10 lines could not be 
screened because the flies died. As a result, this number might increase to about 50 percent. If 
this holds true for the nurse cell candidate FACS analyses, then out of 103, ~40 would remain. 
These numbers of candidates are much more manageable than the amount of candidates 
identified from the fertility screens. Conditioning and execution of the clonal analysis for the 
candidates from the larval salivary gland screen would be concurrent with the nurse cell 
candidate FACS. Having never done the clonal analysis myself, I cannot approximate how many 
candidates I expect will remain but if it is a similar percentage to the candidates identified from 
the follicle cell fertility screen, then I would hope that ~40 out of 109 salivary gland candidates 
would remain.  
The second goal is to continue screening the remaining ~10000 UAS>RNAi lines using 
the same schema as the pilot-screen (Figure 6). Since there is a set protocol and not much 
conditioning needs to be done, it will be performed in a more efficient manner. Out of the 1280 
lines screened in the pilot screening, 216 were identified as possibly being relevant to 
endoreduplication in some way. Given the percentage above, I would expect that after screening 
the remaining UAS>RNAi lines, ~1600 would be identified as possibly being involved in 
endoreduplication. 
The final goal is to further characterize the remaining genes from the secondary screen. 
For instance, I would begin hypothesis-driven experiments with Nup54 to further characterize its 
specific interactions with endoreduplication in Drosophila. Another possibility would be to study 
the identified genes in other organisms which possess greater homology with humans such as 
mice.  If I use mice, I would be able to use the Cre-LoxP system which allows tissue-specific 
knockouts. With this, I could knockout the candidate gene in endoreduplicating mice cells such 
as giant trophoblast cells or hepatocytes. If the gene is necessary for growth, then cells which 
would normally endoreduplicate would theoretically be smaller in size and contain lower DNA 
content than their wild-type counterparts. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 
As I reflect on my undergraduate experience in the field of research, I realized that I had 
a very naïve sense for what was expected. I had two major influences: Human Genome Project 
and the Ebola virus. I was in awe of the daunting task the scientists faced when attempting to 
sequence an entire genome. As a result, I felt challenged to overcome obstacles even greater than 
the Human Genome Project. Even more so, I felt a huge urge to help people and desired to find 
treatments for sicknesses ranging from the common cold to terrible epidemics like the Ebola 
virus. When I first began research, I understood that human beings have gained much insight 
from doing research and that these advances in science have been very beneficial to many 
people. However, I was not ready for what research is and what was involved. If I was to 
summarize my overall experience in research now, I would say it is one of the time-consuming 
but enlightening and rewarding activities in which I have ever participated.  
Reflecting on my experience, I believe the first big shock for me was the realization that 
there are actually two different types of research: hypothesis-driven research and large scale 
input research. When I imagined research, I was under the impression that all of it was 
hypothesis-driven. Research was the process of discovering how to treat diseases or the journey 
of discovering something new and innovative which would immediately resound throughout the 
world. The thought of looking for new interactions and genes through large scale input research 
never occurred to me. As a result, when introduced to the concept of a genome-wide screening, I 
was puzzled. The screening falls into the large scale input-type project and serves to identify 
factors specifically involved in endoreduplication and/or the switch form mitosis to 
endoreduplication.  After using the schema (Figured 5) to identify possible candidates and using 
the secondary screening to further characterize them (Figure 11 and 12), the remaining 
candidates will be tested through more hypothesis-driven research. This ties into future goals and 
will be discussed later. 
Another lesson that I quickly learned was that requires immense amounts of work. I 
slowly began to realize that as a researcher, I needed to have a very different timetable from 
other professions which fall into the typical workday. I found that the model organism, in my 
case Drosophila, dictate the researcher’s timetable, not the other way around. However, when I 
first began, I did not understand this concept. There were many times when I would set up an 
experiment only to fail half-way through because I did not time my experiments correctly. One 
persistent example would be when I had to collect female virgins (females which have yet to 
mate with a male). The developmental lifecycle of Drosophila occurs in the span of 10 days. 
When females emerge, there is a short period of time which I can collect them and be sure they 
are virgins. If the flies emerged during the weekend, I would wait until the weekday to collect 
the females, hoping that there would still be virgins to collect. As a result, I would not be able to 
gather many virgins and if I did not have enough, I would have to wait another 10 days until the 
next generation to collect more. Even though this seems to be inconsequential, the misconception 
of time I possessed while collecting virgins could pose terrible consequences in reference to the 
screening. One severe example would be screening progeny which do not have the correct 
genotype causing collection of incorrect data. These experiences delayed my research a little but 
allowed me to gain a greater understanding of how to budget my time. Moreover, it solidified the 
concept that I was not at the center of my world and that sacrifice is sometimes needed for 
advancement. 
Aside from learning the methodology and how to budget my time, research has taught me 
how to present my research and how to write as well.  For instance, I presented in casual settings 
such as general lab meetings and on multiple occasions would present my research to other 
Drosophila labs. Additionally, I presented at research forums which allowed me create a poster 
and refine how I would present my project in such a setting. Thanks to an immense amount of 
guidance and my hard work, I even received a 2nd award for the 2011 Denman Undergraduate 
Research Forum. The final aspect of research other than experiments which I have learned is 
how to write in a scientific setting. Having applied for many scholarships and fellowships during 
my undergraduate career, I have been graced with one scholarship and am also a recipient of the 
Pelotonia Undergraduate Research Fellowship in 2010 and 2011. The financial support from 
these awards has allowed me to focus more time on my research because I did not have to worry 
about living expenses. Moreover, I was asked to participate in the 2011 Pelotonia Symposium. 
Through this, I acquired the knowledge of orally conveying my research in a more formal 
setting. For the symposium, I produced a presentation where I presented my research to many 
distinguished scientists in the field of cancer research.  In addition, as a Pelotonia fellow, I was 
prompted to participate in certain events which gave me perspectives on research I was never 
aware of such as the Pelotonia, the bike ride to end cancer. After hearing many tragic cancer 
patient stories, I realized the importance my research could potentially have on the world. This 
spurred me forward and gave me even greater enthusiasm towards my research.  
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Figure 1 – Formation of the Pre-Replication Complex in Mitotic Replication 
and Endredouplication 
 
In mitotic replication, the Origin Recognition Complex (ORC) is necessary to 
form the pre-Replicative Complex (pre-RC) which initiates DNA replication. 
However, in endoreduplication, ORC is dispensable. Another protein or set of 
proteins is responsible for the formation of the pre-RC. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 – The GAl4/UAS system with RNAi 
 
The GAL4 protein is transcribed under the control of a tissue-specific promoter. It binds to 
the Upstream Activating Sequence (UAS) and causes transcription of mRNA. The mRNA 
transcribed is an inverse repeat which will form dsRNA and be integrated into the RISC 
complex. The RISC targets homologous mRNA for degradation. 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 – RNAi Pathway 
 
Dicer targets and cuts both siRNA and miRNA. The cut siRNA and miRNA are incorporated 
into the RISC complex which targets homologous sequences of mRNA. If miRNA, is 
incorporated into the RISC, translation of mRNA is inhibited. If siRNA is incorporated, 
mRNA is cleaved. Both methods serve to downregulate protein expression, 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 - Pre-screening of larval salivary glands and wings using dppblk1>GAL4 with and 
without UAS>Dcr-2 
 
Figures A and B. UAS>Dcr-2(-) crosses to dppblk1>GAL4+UAS>GFPnls. 
Figures C and D. UAS>Dcr-2(+) crosses to dppblk1>GAL4+UAS>GFPnls. 
The phenotypes from C are much more severe than the phenotypes from A. The phenotypes 
from D are also more severe than those from B. This demonstrates that UAS>Dcr-2 enhances 
RNAi expression. 
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Figure 5 – Expression of dppblk1>GAL4, GMR>GAL4, c355>GAL4, and VP16nos>GAL4 
and Drosophila oogenesis. 
 
Figure A. dppblk1>GAL4 salivary gland expression utilizing USA>RNAi  in conjunction 
with UAS>Dcr-2 and marked with UAS>GFP.  
Figure B. Wild-type eye phenotype. 
Figure C. GMR>GAL4 expression in the eye (rough eye phenotype).  
Figure D. A cartoon depicting the stages of oogenesis through stage 9 in addition to the 
switch from mitotic replication to endoreduplication. 
Figure E. Expression of c355>GAL4,  the follicle cell driver, marked with GFP. 
Figure F. Expression of VP16nos>GAL4, the nurse cell driver, marked with GFP.  
Figures D-F – So Young Park 
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Figure 6 – Drosophila life cycle and 
the Genome-wide screening schema 
 
Figure A. The developmental cycle 
of Drosophila.  
0 hours – Fertilization occurs.  
0-18 hours – Embryogenesis.  
18 hours-7 days – 1st, 2nd, and 3rd 
instar larval stages.  
7-10 days – Pupation 
10-11 days – Emergence and 
gametogenesis. 
Figure B. Salivary gland screening. 
Figure C. Wing screening. 
Figure D. Follicle cell screening. 
Figure E. Nurse cell screening. 
 
 
 
 
 
Figure A - Scientific Frontiers in 
Developmental Toxicology and Risk 
Assessment (2000) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 – Pilot Screening Results 
 
Red – Salivary gland candidates identified from the pilot screening 
Orange – Follicle cell candidates identified from the pilot screening 
Green – Nurse cell candidates identified from the pilot screening 
Overlaps indicate that the candidate produced a phenotype in both tissues or in the case of 
Nup54, Whgsc2, and Cp7Fa, produced a phenotype in all three tissues. 
Lindsey Kent and Jonathan Lee 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 – Protein Class Summary of Identified Candidates from the pilot Larval 
Salivary Gland Screen 
 
  
 
 
 
 
 
 
 
Figure 9 – Protein Class Summary of Identified Candidates from the pilot 
ovarian follicle cell screen 
 
  
 
 
 
 
 
 
 
Figure 10 – Protein Class Summary of Identified Candidates from the pilot 
ovarian nurse cell screen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
Figure 11 – c355>GAL4 and VP16nos>GAL4 FACS Analysis Profiles 
 
Figure A and B. FACS analysis for c355>GAL4 which is expressed in ovarian follicle cells. A 
is the GAL4 driver itself and B is a Nup54. There is a clear shift downwards in ploidy and the 
16N peak is much smaller than the control. 
Figure C and D. FACS analysis for VP16nos>GAL4 which is expressed in germline nurse 
cells. C is the GAL4 driver itself and D is hikaru genki. The amount of cells counted is different 
but there is still a clear shift downwards in ploidy. 
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Figure 12 – Inducible clonal analysis of a gene using an RNAi transgenic line  
Heat shock will induce flp recombinase expression which removes CD2 and thus activates 
Actin5C promoter to drive the GAL4. Clones will be marked by RFP. 
Maki Asano 
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